Lloyd Damon, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue, #A446
San Francisco CA 94117
Phone415-353-2421
ORCID ORCID Icon0000-0002-7934-5321 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPost-Doc Fellow/Scholar1987 Medicine (Cancer Research Institute)
    University of California, San Francisco Residency School of Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Lloyd Damon is a hematologist and researcher who specializes in blood cancers such as lymphomas and leukemias.

    Damon studies new treatments for acute myeloid and acute lymphoblastic leukemias. In 1995, he was an early investigator of rituximab, the first monoclonal antibody approved to treat human cancer, specifically lymphoma. (Monoclonal antibodies are cancer-fighting molecules produced in the lab and then infused to work with the patient's immune system against cancer.) In 1998, Damon developed a high-dose regimen for mantle cell lymphoma involving autologous stem cell transplants – which use the patient's own stem cells. When studying cytarabine, an important leukemia drug, he discovered the risk factors for an uncommon toxic effect it can have on the brain and then developed a method for modifying the dose that reduces this side effect significantly.

    Damon earned his medical degree at the University of Michigan. He completed an internal medicine residency and a fellowship in hematology and oncology at UCSF, where he joined the faculty in 1988. He is deputy chief of the Divisions of Hematology and Medical Oncology.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults. J Geriatr Oncol. 2023 Nov; 14(8):101623. Huang LW, Shi Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Boscardin WJ, Steinman MA, Olin RL. PMID: 37678052.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients. Bone Marrow Transplant. 2023 11; 58(11):1247-1253. Lee A, Badgley C, Lo M, Banez MT, Graff L, Damon L, Martin T, Dzundza J, Wong M, Olin R. PMID: 37626267; PMCID: PMC10622316.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults. Transplant Cell Ther. 2022 06; 28(6):309.e1-309.e9. Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Huang CY, Olin RL. PMID: 35247612; PMCID: PMC9198006.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2021 10; 22(10):1403-1415. Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT. PMID: 34516954.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCellsCTClinical Trials
    5. Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis. Blood Cancer Discov. 2021 09; 2(5):434-449. Wang VE, Blaser BW, Patel RK, Behbehani GK, Rao AA, Durbin-Johnson B, Jiang T, Logan AC, Settles M, Mannis GN, Olin R, Damon LE, Martin TG, Sayre PH, Gaensler KM, McMahon E, Flanders M, Weinberg V, Ye CJ, Carbone DP, Munster PN, Fragiadakis GK, McCormick F, Andreadis C. PMID: 34514432; PMCID: PMC8425277.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infect Control Hosp Epidemiol. 2021 09; 42(9):1090-1097. Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB. PMID: 33487182; PMCID: PMC8459315.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review. Case Rep Hematol. 2020; 2020:8823877. Valliani S, Ali M, Mahmoo O, Hinduja S, Chen CK, Damon L, Abdulhaq H. PMID: 33425404; PMCID: PMC7781713.
      View in: PubMed   Mentions: 3  
    8. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2021 04; 21(4):246-256.e2. Kambhampati S, Hunter B, Varnavski A, Fakhri B, Kaplan L, Ai WZ, Pampaloni M, Huang CY, Martin T, Damon L, Andreadis CB. PMID: 33288485.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation. J Geriatr Oncol. 2021 05; 12(4):531-539. Nawas MT, Sheng Y, Huang CY, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Olin RL. PMID: 33059999.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer. Mol Ther. 2020 11 04; 28(11):2367-2378. Ko AH, Jordan AC, Tooker E, Lacey SF, Chang RB, Li Y, Venook AP, Tempero M, Damon L, Fong L, O'Hara MH, Levine BL, Melenhorst JJ, Plesa G, June CH, Beatty GL. PMID: 32730744; PMCID: PMC7647666.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    11. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature. Anticancer Res. 2020 Jul; 40(7):3995-4000. Burns ST, Damon L, Akagi N, Laszik Z, Ko AH. PMID: 32620643.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma. Biol Blood Marrow Transplant. 2020 05; 26(5):876-883. Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, Leavitt AD, Loeffler P, Martin TG. PMID: 31785375.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man. JAMA Neurol. 2019 Nov 01; 76(11):1397-1398. Gupta S, Damon L, Gelfand JM. PMID: 31524939.
      View in: PubMed   Mentions:    Fields:    
    14. Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2020 01; 26(1):189-196. Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Steinman MA, Huang CY, Olin RL. PMID: 31493541; PMCID: PMC6942208.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    15. Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results. Clin Cancer Res. 2019 08 15; 25(16):4917-4923. Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C. PMID: 31152020.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    16. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Lancet Haematol. 2019 Mar; 6(3):e132-e143. Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J. PMID: 30824040; PMCID: PMC6503965.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCTClinical Trials
    17. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 06; 25(6):1218-1224. Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Huang CY, Olin RL. PMID: 30708189.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    18. The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia. Case Rep Hematol. 2018; 2018:7267920. Rahmat LT, Damon LE. PMID: 30662779; PMCID: PMC6312608.
      View in: PubMed   Mentions: 5  
    19. High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial. J Adolesc Young Adult Oncol. 2018 10; 7(5):546-552. Schiller GJ, Damon LE, Coutre SE, Hsu P, Bhat G, Douer D. PMID: 30239252.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    20. NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017. J Natl Compr Canc Netw. 2017 09; 15(9):1091-1102. Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, Barta SK, Boyer MW, Bryan T, Burke PW, Cassaday R, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Frankfurt O, Greer JP, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Mattison R, Park J, Rubnitz J, Saad A, Uy GL, Wang ES, Gregory KM, Ogba N. PMID: 28874594.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    21. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 11; 22(11):1974-1982. Mulé MP, Mannis GN, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS. PMID: 27544285; PMCID: PMC5072749.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. The use of ibrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2016 Mar; 14(3):154-6. Damon LE. PMID: 27058026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 06; 22(6):1030-1036. Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KML, Sayre PH, Wolf JL, Logan AC. PMID: 26899561.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    24. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 07; 57(7):1560-6. Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. PMID: 26490487.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Acute Lymphoblastic Leukemia, Version 2.2015. J Natl Compr Canc Netw. 2015 Oct; 13(10):1240-79. Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U, Boyer MW, Burke PW, Cassaday R, Castro JE, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Douer D, Frankfurt O, Greer JP, Johnson RA, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Rao AV, Shah B, Uy GL, Wang ES, Zelenetz AD, Gregory K, Smith C. PMID: 26483064.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    26. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. Lancet Oncol. 2015 Sep; 16(9):1025-1036. Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM. PMID: 26234174; PMCID: PMC4822512.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    27. KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia. J Immunol. 2015 May 01; 194(9):4222-30. Marra J, Greene J, Hwang J, Du J, Damon L, Martin T, Venstrom JM. PMID: 25810393.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    28. Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia. J Clin Oncol. 2015 Apr 10; 33(11):1252-7. Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon SR, Venugopal P, Lundberg AS, Powell B. PMID: 25732165.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    29. A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83. Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. PMID: 25776193.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    30. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015 Feb 26; 125(9):1367-76. Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, Pigneux A, Wetzler M, Stuart RK, Erba HP, Damon LE, Powell BL, Lindeman N, Steensma DP, Wadleigh M, DeAngelo DJ, Neuberg D, Stone RM, Ebert BL. PMID: 25550361; PMCID: PMC4342352.
      View in: PubMed   Mentions: 381     Fields:    Translation:Humans
    31. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4. Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. PMID: 25243620.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    32. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. J Geriatr Oncol. 2014 Jul; 5(3):238-44. Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL. PMID: 24894413.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    33. Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML. Blood. 2014 May 22; 123(21):3239-46. Lancet JE, Cortes JE, Hogge DE, Tallman MS, Kovacsovics TJ, Damon LE, Komrokji R, Solomon SR, Kolitz JE, Cooper M, Yeager AM, Louie AC, Feldman EJ. PMID: 24687088; PMCID: PMC4624448.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCTClinical Trials
    34. Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1047-55. O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M, National Comprehensive Cancer Network. PMID: 24029121; PMCID: PMC4161234.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    35. A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma). Semin Oncol. 2012 Dec; 39(6):e37-46. Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ. PMID: 23206848; PMCID: PMC3969822.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood. 2013 Jan 31; 121(5):745-51. Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E, Batchelor T, Krouwer H, Hwang J, Auerback G, Kadoch C, Lowell C, Munster P, Cha S, Shuman MA, Damon LE. PMID: 23197589; PMCID: PMC3563362.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    37. High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. J Clin Oncol. 2013 Feb 20; 31(6):676-83. O'Brien S, Schiller G, Lister J, Damon L, Goldberg S, Aulitzky W, Ben-Yehuda D, Stock W, Coutre S, Douer D, Heffner LT, Larson M, Seiter K, Smith S, Assouline S, Kuriakose P, Maness L, Nagler A, Rowe J, Schaich M, Shpilberg O, Yee K, Schmieder G, Silverman JA, Thomas D, Deitcher SR, Kantarjian H. PMID: 23169518; PMCID: PMC4979201.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsCTClinical Trials
    38. A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. Leuk Lymphoma. 2013 Feb; 54(2):321-8. Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J. PMID: 22906162.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    39. NCCN Clinical Practice Guidelines Acute myeloid leukemia. J Natl Compr Canc Netw. 2012 Aug; 10(8):984-1021. O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, Naganuma M, Gregory KM. PMID: 22878824.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    40. Acute lymphoblastic leukemia. J Natl Compr Canc Netw. 2012 Jul 01; 10(7):858-914. Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM, National Comprehensive Cancer Network. PMID: 22773801.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    41. Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Horm Metab Res. 2012 Jun; 44(7):539-42. Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P. PMID: 22588707.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. 20q- clonality in a case of oral sweet syndrome and myelodysplasia. Am J Clin Pathol. 2012 Feb; 137(2):310-5. Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, Damon L, McCalmont TH, Jordan R, Wolf J. PMID: 22261459.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    43. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012 Feb 15; 18(4):1146-55. Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL. PMID: 22228634; PMCID: PMC3288204.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    44. Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909. Haematologica. 2012 Apr; 97(4):579-85. Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W. PMID: 22102709; PMCID: PMC3347669.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    45. Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol. 2012 Jan; 87(1):123-5. Naidus E, Damon L, Schwartz BS, Breed C, Liu C. PMID: 22052650.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    46. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk Lymphoma. 2011 Dec; 52(12):2237-53. Stock W, Douer D, DeAngelo DJ, Arellano M, Advani A, Damon L, Kovacsovics T, Litzow M, Rytting M, Borthakur G, Bleyer A. PMID: 21827361.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    47. Acute myeloid leukemia. J Natl Compr Canc Netw. 2011 Mar; 9(3):280-317. O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Coutre SE, Damon LE, Foran JM, Goorha S, Maness LJ, Marcucci G, Maslak P, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, National Comprehensive Cancer Network. PMID: 21393440.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    48. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis. 2010 Dec; 16(12):1910-7. Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL. PMID: 21122221; PMCID: PMC3294592.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    49. Autologous hematopoietic cell transplantation for high-risk ALL. Bone Marrow Transplant. 2011 Mar; 46(3):460-1. Linker C, Damon L, Martin T, Blume K, Forman S, Snyder D, Wolf J, Negrin R. PMID: 20531287.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review. Transplant Proc. 2009 Dec; 41(10):4431-3. Mawad R, Hsieh A, Damon L. PMID: 20005417.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    51. Mobilization of hematopoietic stem cells into the peripheral blood. Expert Rev Hematol. 2009 Dec; 2(6):717-33. Damon LE, Damon LE. PMID: 21082960.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    52. Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. J Clin Oncol. 2009 Dec 20; 27(36):6101-8. Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP. PMID: 19917845; PMCID: PMC2793032.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    53. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2010 Feb; 12(1):45-50. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C. PMID: 19793068.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol. 2009 Sep 01; 27(25):4162-8. Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P. PMID: 19636009; PMCID: PMC2734428.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    55. Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Rep. 2009 Jul 06; 3:7335. Behler CM, Terrault NA, Etzell JE, Damon LE. PMID: 19830190; PMCID: PMC2737792.
      View in: PubMed   Mentions: 7     Fields:    
    56. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML). Blood. 2009 Aug 27; 114(9):1736-45. Borrello IM, Levitsky HI, Stock W, Sher D, Qin L, DeAngelo DJ, Alyea EP, Stone RM, Damon LE, Linker CA, Maslyar DJ, Hege KM. PMID: 19556425; PMCID: PMC2738565.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsCTClinical Trials
    57. Auto-SCT for AML in second remission: CALGB study 9620. Bone Marrow Transplant. 2009 Sep; 44(6):353-9. Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, Larson RA, Cancer and Leukemia Group B. PMID: 19289999.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    58. Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk Lymphoma. 2008 Nov; 49(11):2081-90. Hsi ED, Jung SH, Lai R, Johnson JL, Cook JR, Jones D, Devos S, Cheson BD, Damon LE, Said J. PMID: 19021050; PMCID: PMC4011712.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    59. Acute myeloid leukemia. J Natl Compr Canc Netw. 2008 Nov; 6(10):962-93. O'Donnell MR, Appelbaum FR, Coutre SE, Damon LE, Erba HP, Foran J, Lancet J, Maness LJ, Marcucci G, Maslak PG, Millenson M, Moore JO, Ravandi F, Schuening F, Shami P, Smith BD, Stone RM, Tallman MS, Wang E, White FL. PMID: 19176196.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma. Bone Marrow Transplant. 2008 Nov; 42(10):649-57. Damon L, Damon LE, Gaensler K, Kaplan L, Martin T, Rubenstein J, Linker C. PMID: 18679366; PMCID: PMC4372391.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    61. Non-Hodgkin's lymphomas. J Natl Compr Canc Netw. 2008 Apr; 6(4):356-421. Zelenetz AD, Advani RH, Byrd JC, Czuczman MS, Damon LE, Duvic M, Fayad L, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kaminski MS, Kim YH, Lacasce AS, Nademanee A, Olsen EA, Porcu P, Press O, Prosnitz L, Smith MR, Sotomayor EM, Vose JM, Yahalom J, Yunus F, National Comprehensive Cancer Network. PMID: 18433606.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol. 2008 Jan 01; 26(1):96-105. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL. PMID: 18056677; PMCID: PMC4134101.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    63. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol. 2007 Apr 10; 25(11):1350-6. Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M. PMID: 17312328.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCTClinical Trials
    64. Amyloidosis localized to the liver. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):e7. Fix OK, Damon LE, Bass NM. PMID: 17296524.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion. 2006 Oct; 46(10):1693-704. Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG. PMID: 17002625.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    66. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann N Y Acad Sci. 2006 Aug; 1073:465-90. Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK. PMID: 17102115.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    67. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. Biol Blood Marrow Transplant. 2006 Mar; 12(3):316-24. Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C. PMID: 16503501.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Mar; 4(3):258-310. Zelenetz AD, Advani RH, Buadi F, Cabanillas F, Caligiuri MA, Czuczman MS, Damon LE, Fayad L, Flinn IW, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Kaminski MS, Lacasce AS, Nademanee A, Porcu P, Press O, Prosnitz L, Smith MR, Sotomayor EM, Vose JM, Yahalom J, National Comprehensive Cancer Network. PMID: 16507273.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    69. Acute myeloid leukemia clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Jan; 4(1):16-36. O'Donnell MR, Appelbaum FR, Baer MR, Byrd JC, Coutre SE, Damon LE, Erba HP, Estey E, Foran J, Lancet J, Maness LJ, Maslak PG, Millenson M, Moore JO, Przepiorka D, Shami P, Smith BD, Stone RM, Tallman MS. PMID: 16403402.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    70. High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer. Am J Clin Oncol. 2005 Apr; 28(2):130-7. Chaudhary UB, Damon LE, Rugo HS, Linker CA, Navarro W, Small EJ. PMID: 15803005.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    71. ACCO: ASCO core curriculum outline. J Clin Oncol. 2005 Mar 20; 23(9):2049-77. Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J, American Society of Clinical Oncology. PMID: 15728218.
      View in: PubMed   Mentions: 14     Fields:    
    72. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation. 2004 Dec 15; 78(11):1582-9. Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST. PMID: 15591945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    73. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia. Am J Hematol. 2004 Dec; 77(4):331-5. Beinart G, Damon L. PMID: 15551293.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    74. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. J Clin Oncol. 2004 May 15; 22(10):1839-48. Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Yen Y, Damon L, Doroshow JH. PMID: 15143076.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    75. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer Chemother Pharmacol. 2004 Jun; 53(6):468-74. Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA. PMID: 15138711.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    76. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone Marrow Transplant. 2003 Dec; 32(12):1153-7. Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G, Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation, German Adjuvant Breast Cancer Study Group, University of California, San Francisco. PMID: 14647269.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    77. High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant. 2003 Oct; 9(10):643-8. Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C. PMID: 14569560.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    78. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol. 2002 May 15; 20(10):2464-71. Linker C, Damon L, Ries C, Navarro W. PMID: 12011123.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    79. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone Marrow Transplant. 2002 Feb; 29(4):297-301. Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. PMID: 11896426.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    80. The Trauma Symptom Checklist for Young Children (TSCYC): reliability and association with abuse exposure in a multi-site study. Child Abuse Negl. 2001 Aug; 25(8):1001-14. Briere J, Johnson K, Bissada A, Damon L, Crouch J, Gil E, Hanson R, Ernst V. PMID: 11601594.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    81. Child Sexual Behavior Inventory: normative, psychiatric, and sexual abuse comparisons. Child Maltreat. 2001 Feb; 6(1):37-49. Friedrich WN, Fisher JL, Dittner CA, Acton R, Berliner L, Butler J, Damon L, Davies WH, Gray A, Wright J. PMID: 11217169.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    82. A case of factitious aplastic anemia. Int J Psychiatry Med. 2001; 31(4):433-41. Bright R, Eisendrath S, Damon L. PMID: 11949741.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    83. High-dose chemotherapy (CTM) for breast cancer. Bone Marrow Transplant. 2000 Aug; 26(3):257-68. Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA. PMID: 10967563.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    84. High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California. Biol Blood Marrow Transplant. 2000; 6(5):496-505. Damon LE, Hu WW, Stockerl-Goldstein KE, Blume KG, Wolf JL, Gold E, Cecchi GR, Irwin D, Glaspy J, Territo I, Miller W, Mason JR, Linker CA. PMID: 11063378.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol Blood Marrow Transplant. 2000; 6(1):50-7. Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolfe JL. PMID: 10707999.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    86. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transplant. 1998 Nov; 22(9):865-72. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. PMID: 9827814.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia. 1997 Apr; 11(4):485-9. Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC, Beer M, Ahmed T. PMID: 9096687.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    88. Successful immunomodulation with intravenous gamma globulin and cyclophosphamide in an alloimmunized heart transplant recipient. J Heart Lung Transplant. 1997 Mar; 16(3):360-5. De Marco T, Damon LE, Colombe B, Keith F, Chatterjee K, Garovoy MR. PMID: 9087880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol. 1997 Feb; 15(2):833-9. Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA. PMID: 9053511.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    90. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation. Endoscopy. 1996 Oct; 28(8):680-5. Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW. PMID: 8934085.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    91. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study. Bone Marrow Transplant. 1996 Sep; 18 Suppl 1:S24-5. Zander AR, Krüger W, Kröger N, Damon L, Königmann M, Berdel WE, Gieseking F, Schäfer-Eckart K, Möbus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wörmann B, Trümper L, Huber C, Hossfeld DK, Maass H, Jonat W. PMID: 8899165.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    92. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Bone Marrow Transplant. 1996 Jan; 17(1):93-9. Damon LE, Rugo HS, Ries CA, Linker CA. PMID: 8673063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol. 1995; 15(5):431-5. Lipschutz JH, Miller T, Yen TS, Vartanian RK, Graber ML, Damon L. PMID: 7503144.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Leukemia. 1994 Apr; 8(4):535-41. Damon LE, Rugo HS, Ries CA, Linker CA. PMID: 8152248.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma. Prog Clin Biol Res. 1994; 389:505-11. Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA. PMID: 7535460.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    96. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Semin Oncol. 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. PMID: 8342075.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease. Cancer. 1993 Aug 01; 72(3):905-8. Small EJ, Venook AP, Damon LE. PMID: 8334644.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant. 1993 May-Jun; 12(3):440-4. Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, DeMarco T. PMID: 8329415.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    99. Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood. 1993 Jan 15; 81(2):311-8. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. PMID: 8422457.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992 Oct 15; 80(8):1890-5. Thompson CE, Damon LE, Ries CA, Linker CA. PMID: 1391952.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    101. Anemias of chronic disease in the aged: diagnosis and treatment. Geriatrics. 1992 Apr; 47(4):47-54, 57. Damon LE. PMID: 1555779.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1991 Aug 15; 51(16):4141-5. Damon LE, Plunkett W, Linker CA. PMID: 1868435.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines. Anticancer Res. 1989 Nov-Dec; 9(6):1761-7. Damon LE, Christensen S, Rochlitz C, Cadman EC. PMID: 2534035.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    104. The association between high-dose cytarabine neurotoxicity and renal insufficiency. J Clin Oncol. 1989 Oct; 7(10):1563-8. Damon LE, Mass R, Linker CA. PMID: 2778484.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    105. Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol Ther. 1989; 43(2):155-85. Damon LE, Cadman E, Benz C. PMID: 2675132.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    106. Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemother Pharmacol. 1988; 21(4):319-22. Rochlitz CF, Damon LE, Russi MB, Geddes A, Cadman EC. PMID: 3370740.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    107. The metabolic basis for combination chemotherapy. Pharmacol Ther. 1988; 38(1):73-127. Damon LE, Cadman EC. PMID: 3293090.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    108. Intracranial bleeding during treatment with hydroxyethyl starch. N Engl J Med. 1987 Oct 08; 317(15):964-5. Damon L, Adams M, Stricker RB, Ries C. PMID: 2442613.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    109. Treatment issues with sexually abused young children. Child Welfare. 1987 Mar-Apr; 66(2):125-37. Damon L, Todd J, MacFarlane K. PMID: 3829778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. A videotape parent education program for abusive parents. Child Abuse Negl. 1987; 11(2):255-65. Golub JS, Espinosa M, Damon L, Card J. PMID: 2439178.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Advances in rational combination chemotherapy. Cancer Invest. 1986; 4(5):421-44. Damon LE, Cadman EC. PMID: 3542142.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    112. Effects of relocation on the elderly. Am Fam Physician. 1982 Nov; 26(5):144-8. Damon LE. PMID: 7148624.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Lloyd's Networks
    Concepts (484)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (78)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.